PIGR
Polymeric immunoglobulin receptor
Also known as: PIGR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01833
- Gene
- PIGR
- Ensembl
- ENSG00000162896
- Chromosome
- 1
- Canonical length
- 764 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
This gene is a member of the immunoglobulin superfamily. The encoded poly-Ig receptor binds polymeric immunoglobulin molecules at the basolateral surface of epithelial cells; the complex is then transported across the cell to be secreted at the apical surface. A significant association was found between immunoglobulin A nephropathy and several SNPs in this gene.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
764 residues, UniProt reviewed canonical sequence.
>P01833|PIGR
1 MLLFVLTCLL AVFPAISTKS PIFGPEEVNS VEGNSVSITC YYPPTSVNRH TRKYWCRQGA
61 RGGCITLISS EGYVSSKYAG RANLTNFPEN GTFVVNIAQL SQDDSGRYKC GLGINSRGLS
121 FDVSLEVSQG PGLLNDTKVY TVDLGRTVTI NCPFKTENAQ KRKSLYKQIG LYPVLVIDSS
181 GYVNPNYTGR IRLDIQGTGQ LLFSVVINQL RLSDAGQYLC QAGDDSNSNK KNADLQVLKP
241 EPELVYEDLR GSVTFHCALG PEVANVAKFL CRQSSGENCD VVVNTLGKRA PAFEGRILLN
301 PQDKDGSFSV VITGLRKEDA GRYLCGAHSD GQLQEGSPIQ AWQLFVNEES TIPRSPTVVK
361 GVAGGSVAVL CPYNRKESKS IKYWCLWEGA QNGRCPLLVD SEGWVKAQYE GRLSLLEEPG
421 NGTFTVILNQ LTSRDAGFYW CLTNGDTLWR TTVEIKIIEG EPNLKVPGNV TAVLGETLKV
481 PCHFPCKFSS YEKYWCKWNN TGCQALPSQD EGPSKAFVNC DENSRLVSLT LNLVTRADEG
541 WYWCGVKQGH FYGETAAVYV AVEERKAAGS RDVSLAKADA APDEKVLDSG FREIENKAIQ
601 DPRLFAEEKA VADTRDQADG SRASVDSGSS EEQGGSSRAL VSTLVPLGLV LAVGAVAVGV
661 ARARHRKNVD RVSIRSYRTD ISMSDFENSR EFGANDNMGA SSITQETSLG GKEEFVATTE
721 STTETKEPKK AKRSSKEEAE MAYKDFLLQS STVAAEAQDG PQEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIGR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 2,479 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 2,479 nTPM
- colon: 1,586 nTPM
- salivary gland: 1,544 nTPM
- rectum: 1,149 nTPM
- small intestine: 761 nTPM
- cervix: 514 nTPM
Single-cell type
- colonocytes: 8,431 nCPM
- lacrimal acinar cells: 5,520 nCPM
- enteric transient amplifying cells: 4,471 nCPM
- enteric stem cells: 3,465 nCPM
- salivary acinar cells: 2,959 nCPM
- prostatic club cells: 2,770 nCPM
Immune cell
- memory B-cell: 0.9 nTPM
- naive B-cell: 0.8 nTPM
- basophil: 0.3 nTPM
- myeloid DC: 0.3 nTPM
- neutrophil: 0.3 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- thalamus: 3 nTPM
- white matter: 3 nTPM
- cerebellum: 2.8 nTPM
- cerebral cortex: 2.8 nTPM
- hippocampal formation: 2.7 nTPM
- pons: 2.7 nTPM
ReferencesPubMed · IEDB
Publications for PIGR from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis.
2023 · Nat Commun · RCR 4.8 · 50 citations - PIgR Autoantibody-abundant Circulating Vesicles Contributes to Biliary Injury in Biliary Atresia.
2025 · J Pediatr Surg · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- detection of chemical stimulus involved in sensory perception of bitter taste
- epidermal growth factor receptor signaling pathway
- Fc receptor signaling pathway
- immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor
- receptor clustering
- signal transduction
Molecular functions
- polymeric immunoglobulin binding
- transmembrane signaling receptor activity
- polymeric immunoglobulin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIGR as an antibody target. Whether an autoantibody or antibody against PIGR could matter depends on whether native PIGR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIGR is annotated at the cell surface, where native PIGR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PIGR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...